Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Directorate Change

3 Apr 2008 15:22

Halma PLC03 April 2008 Halma p.l.c. BOARD RETIREMENT AND APPOINTMENT Halma p.l.c., the leading safety, health and sensor technology group, todayannounces the forthcoming retirement of Keith Roy as an Executive Director andthe appointment of Adam Meyers to the Board. Keith Roy, 57, has given notice that he will retire and resign as a Directorwith effect from 31 July 2008. In accordance with Halma's internal successionplanning processes and to ensure a smooth handover, Adam Meyers will beappointed as an Executive Director with immediate effect. Adam Meyers, 46, has been a member of Halma's Executive Board since April 2003as the Divisional Chief Executive responsible for the Fluid Technology Divisionwithin Halma's Health and Analysis sector. Prior to that, he was an AssistantDivisional Chief Executive and President of Bio-Chem Valve, having joined theGroup in 1996. He is a graduate of the University of Pennsylvania and has anMBA from Harvard Business School. Geoff Unwin, Halma's Chairman, commented: "I would like to record my thanks to Keith Roy who has made a tremendouscontribution to the success of Halma since he sold his business to the group in1993. Amongst his many achievements, Keith has been unceasing in his efforts todevelop talent throughout the organisation. The value of this is clearly seenby the increase in internal promotions in recent years, particularly at HalmaExecutive Board level. "We welcome Adam Meyers to the Halma Board. In his 11 years with the group,Adam has built a strong track record of achievement contributing both consistentorganic growth and acquisitions to our success. His knowledge of many of ourHealth and Analysis markets, particularly in the US, will bring an addeddimension to the Board." For further information, please contact: Andrew Williams, Chief Executive +44 (0)1494 721111Halma p.l.c. Rachel Hirst/Andrew Jaques +44 (0)20 7357 9477Hogarth Partnership Limited Notes i) A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com ii) At the date of this announcement Adam Meyers has the following interests in the ordinary shares of Halma: - a beneficial interest in 41,689 shares (of which 4,544 are held via the Halma Holdings Inc. Profit Sharing Savings Retirement Plan (a 401k plan)) - outstanding options in respect of 503,881 shares at a weighted average exercise price per share of 132.64 pence - outstanding Performance Share Plan awards in respect of 226,368 shares vesting from August 2008. Adam Meyers has not held any directorships of publicly quoted companies in thelast five years. There are no further details to disclose under paragraph9.6.13 of the Listing Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.